Justera Revenue Boosts with Launching of Cutera XEO Laser Treatment and Plan to Expand

Toronto, Ontario–(Newsfile Corp. – November 20, 2023) – Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) (“Justera” or the “Company“) is pleased to announce that the Company’s wholly-owned subsidiary, Juillet Wellness Centre (“Juillet Wellness“), has seen a significant revenue boost following the introduction of its premium laser treatment services, powered by CUTERA XEO (“XEO”).

The Company is pleased to note that the revenue of laser treatment has grown rapidly to total sales, since the recent launch of premium laser treatment services with CUTERA XEO (“XEO“). XEO, a product of Cutera Face and Body Aesthetic Solutions (CUTERA), is recognized as a leading name in the industry and is celebrated for its innovative approach to non-surgical aesthetic treatments.

This sales boost has inspired Justera to consider expanding its range of laser treatment offerings. Plans are in motion to incorporate more devices in the near future, further diversifying the company’s services in this domain.

“We are thrilled to witness the remarkable success of our Juillet Wellness, as reflected in the rapid growth of laser treatment sales. The introduction of the CUTERA XEO has proven to be a significant development. This success fuels our enthusiasm to explore further diversification in laser treatments and reinforcing our position at the health and wellness industry,” said Edward Park, Chief Executive Officer of the Company.

About XEO

XEO is a premium laser platform designed for skin revitalization and resurfacing, pigmented lesions, vascular lesions and hair removal. It is a customizable, multi-application laser, and light-based platform designed to treat the widest range of today’s most common nonsurgical aesthetic concerns. Applications include acne scars, age spots, angiomas, compromised skin, deep dermal heating, freckles, inflammatory active acne, hair removal, lentigines, photodamage, poikiloderma, rosacea, scar reduction, facial veins, leg veins, periorbital veins, venous lakes, warts, wrinkles and more.

To learn more, please visit: https://www.cutera.com/solutions/xeo/

About CUTERA

Cutera was founded in 1998 by veteran laser and optical engineers with a vision of offering the best solutions for achieving superior outcomes in the next frontier of medical aesthetics. Cutera aims to define the leading medical aesthetics with devices that appeal to forward-thinking clinicians who need the highest level of performance, safety, and efficacy in their practices.

To learn more about Cutera, please visit: https://www.cutera.com

About Juillet Wellness

Juillet Wellness is a full-service wellness center that offers a convenient and harmonious facility, bringing together a wide range of essential beauty and wellness services under one clinic. With skilled staff and premium products, Juillet Wellness provides a luxurious experience. The wellness center offers various treatments, including registered massage therapy (RMT), physiotherapy, and traditional Chinese medicine through acupuncture, promoting balance and vitality. Juillet Wellness now also offers premium laser treatment services with the addition of CUTERA XEO.

About Justera

Established in 2020, Justera Health Ltd. is a Canadian Company focused on health and wellness. Through its services, innovative products, strategic partnerships, Justera empowers individuals to prioritize their well-being. With four subsidiaries, it offers personalized healthcare services and solutions, such as IV Vitamin Therapy, premium nutritional supplements through its Naturevan Nutrition brand, a full 360-degree wellness and spa experience through Juillet Wellness that provides registered massage therapy, acupuncture, and new retail stores in Vancouver. Justera’s mission is to enhance Canadians overall well-being with diverse solutions catering to individual needs.

For additional information on Justera and other corporate information, please visit the Company’s website at www.justerahealth.com.

For more information about the Company, please refer to the Company’s profile on SEDAR+ at www.sedarplus.ca.

Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

For further information:

Investor Relations & Communications

Edward Park, Chief Executive Officer
Tel: (416) 901-5611 x 203
Email: epark@justerahealth.com

Forward-Looking Statements:

Certain statements contained in this news release may constitute forward-looking information, including statements relating to the future development of Justera’s business. Forward-looking information is often, but not always, identified by the use of words such as “anticipate”, “plan”, “estimate”, “expect”, “may”, “will”, “intend”, “should”, and similar expressions. Forward-looking information involves known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. The actual results of Justera could differ materially from those anticipated in this forward-looking information as a result of regulatory decisions, competitive factors in the industries in which Justera operates, prevailing economic conditions, changes to Justera’s strategic growth plans, and other factors, many of which are beyond the control of Justera. Management of Justera believes that the expectations reflected in the forward-looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents Justera’s expectations as of the date hereof and is subject to change after such date. Justera disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events, or otherwise, except as required by applicable securities legislation.

###

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/187922

Staff

Recent Posts

Hemogenyx Pharmaceuticals PLC Announces IRB Approval for Phase I Clinical Trial

Hemogenyx Pharmaceuticals Receives IRB Approval for Phase 1 Clinical Trial of HEMO-CAR-T (HG-CT-1)LONDON, UK /…

3 hours ago

Modular Medical Announces Pricing of $8.2 Million Public Offering

SAN DIEGO, CA / ACCESSWIRE / November 21, 2024 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular…

6 hours ago

Nicole Garrett and Under Pressure Hyperbarics Lead the Charge in Wellness Education With Immersive Events at L.A. Fashion Weekend and Beyond

BEVERLY HILLS, CALIFORNIA / ACCESSWIRE / November 21, 2024 / Nicole Garrett, CEO of Under…

9 hours ago

Beacon Healthcare Systems Expands Leadership Team with Addition of Ayman Mohamed as Chief Technology Officer

HUNTINGTON BEACH, Calif., Nov. 21, 2024 /PRNewswire/ -- Beacon Healthcare Systems, is pleased to announce…

12 hours ago

Talkiatry Ranked Number 6 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Attributes Revenue Growth to Innovative Partnerships, Strong Team, and Unique Value-Based Care Model NEW YORK,…

12 hours ago

Bright Light Imaging Leverages Alpha Nodus’s Gravity Auth, Enhanced by Integration with ADS’s MedicsRIS, to Streamline Patient Care

Automation That Makes a Difference SUNRISE, Fla., Nov. 21, 2024 /PRNewswire/ -- When it comes…

12 hours ago